Term
|
Definition
Arachidonic-Cox 1 & Cox 2-immune response
Lipooxygenase--bronchoconstriction, vasoconstriction (Zileuton stops this)
Steroids can stop arachidonic acid
|
|
|
Term
|
Definition
Smooth muscle, vascular endothelium, brain
Causes bronchoconstriction=asthma
Erythema, itching, pain, edema
(antihistamines targets these best) |
|
|
Term
H1 Antihistamines
Inverse Agonists=stabilizes the inactive H1
Seven-transmembrane G protein couples.
Excellant absorption=CMAX 2-3 hours.
|
|
Definition
1st Generation: Lipohilic, neutral at physiologic pH
Cross BBB=causing sedation
(diphenhydramine, Hydroxyzine, chlorpheniramine, promethazine, doxepin.)
2nd Generation: Albumin binding, ionized at physiologic pH
(Loratidine, desloratidine-more active form, cetririzine, levocetirizine, fexofenadine)
PK:Absorption: 2-3 hr.
Distribution: 1st gen=nutral pH, lipophilic, crosses BBB. 2nd gen=polarized, hydrophilic, protein bound, decrease SE.
Metabolism: CP350
Elimination: Urine
SE: 1st gen: Cant pee, see, spit, shit, sedation
|
|
|
Term
Efficacy of H1 Antihistamines
(Dephenhydramine, hydroxyzine, chlorpheniramine, promethazine, doxepin)
(Loratidine, desloratidine, cetriizine, levocetrizine, fexofenadine) |
|
Definition
uses: Rhinitis, cojuctivitis, urticaria, pruritis
Motion Sickness, Chemo N/V, Insominia (doxylaminie)
AE: CNS=sedative effects, qt interval prolongation, dryness, pupillary dilation, urinary hesitancy
|
|
|
Term
|
Definition
Sypathetic tone=bronchodilation by B2
Parasympathetic tone=Bronchoconstriction
- Mild Intermittent: less than 2 times a week. short acting (albuterol)
- Mild Persistent: more than 2 times a week. short acting (albuterol), low-dose steroid (beclomethasone), can use theophylline
- Moderate: Daily symptoms. (albuterol),medium-dose corticosteroid (beclomethasone), theophylline
- Severe: continual symptoms, (Albuterol), high-dose steroid. and LABA ( Salmeterol, Formoterol)
|
|
|
Term
Asthma Drugs (mild inter, mild persis, moderate, severe)
Bronchodilators
|
|
Definition
MOA: B-agonists-variable receptor selectivity:
Epi: B2,B1,A (rairly used)
Isoproterenol: B2,B1
Metaproterenol: B2,B1
Terbutaline, Albuterol, Pirbuterol, Bitolterol: B2
Levalbuterol (isolated steroisomer)-B2
Rapid onset of action, Fast peak effect, short duration of action. Used prophylactically before known trigger. |
|
|
Term
Asthma Drugs (Severe)
Long-Acting Beta-agonists (LABA)
Salmeterol, Formoterol |
|
Definition
MOA: lipophilic sides that resist degredation. Lower onset so not for flairs. Last 12-24 hours. Good Prevention of bronchoconstriction.
Do not use as monotherapy-Black Box Warning for asthma related deatyh & pediatric hospitalizaiton)
Use w/ corticosteroids
Watch cardiac for toxicity-because Agonism of Beta 1 can occur |
|
|
Term
Asthma Drugs
Anticholinergics |
|
Definition
- Competive antagonist at ACE & M3
- Used in asthma and COPD
- M3 smooth muscle relaxation and mucous secretion in airway.
- Atropin: Not used for asthma, Highly absorbed accross respiratiory epithelium AE: Tachycardia, N, Dry mouth, GI upset (anticholenergic)
- Ipratropium Bromide: (charged) ammonium salt dirivative of atropine. Not significantly absorbed. Deposition in the mouth and inadvertent oral absorption.
- Tiotropium: (charged) similar to ipratropium but longer lasting (slow dissociation from receptors.
|
|
|
Term
Asthma Drugs (mild, moderate)
Methylxanthines
Theophyline, Aminophyline |
|
Definition
Adenosin Receptor ANTAGONISM
Works in Conjunction with Beta Agonist
MOA: Nonselective, narrow therapeutic index, CYP450 & IA2 drug interactions.
Cigarett smoking increases CYP & IA2
Inhibition of PDE, Airway smooth muscle broncohdilation. also an antiinflammatory.
Adenosine receptor antagonism-secondary effects: increase ventilation, increase endurance, decrease mast cell release.
AE: N/V/D, HA, irratibility, insomnia, seizures, hypokalemia, hypotension, arrhythimias, brain damage, death. So decrease use of drugs now!
Pharmacokinetics: the more CAMP=PKA=Better Bronchodilation |
|
|
Term
Anti-inflammatory Agents/Asthma (mild persisten, moderate, severe)
Corticosteroids
Inhaled: Beclomethasone, Trimecinolone, Fluticasone (combined with salmeterol), Budesonide (can be combined with formoterol), Flunisoilide, mometasone, ciclesonide. |
|
Definition
MOA: increase B2 & anti-inflammatory proteins
Reversal of many Asthma features
NOT A CURE-on supresses
Admin:
Inhaled: 25% reaches airway so need higher dose than PO. If swalloed PO or Inhaled will undergo first pass.
Systemic: only in severe cases becuse of AE.
AE: osteopenia, osteoporosis, delayed growth in children, oropharyngeal candidais, hoarsness, hyperglycemia
Interactions: watch with other drugs that could cause a decrease in first pass because can result in AE worsening (cushings)
|
|
|
Term
Anti-Inflammatory/Astma
Cromolyns
Cromylyn, Nedocromil |
|
Definition
MOA: stabilize mast cells. Inhibit release of inflammatory agents. Prophylactic therapy. less systemic Absorbtion.
DO NOT RELIEVE AN ALLERGIC RESPONSE AFTER INITIATION. |
|
|
Term
Anti-Inflammatory/Astma
Leukotriene Inhibitors
Zileuton, Monetelakast, Zefirukast |
|
Definition
MOA: Breaks down arachidonic acid/ or inhibits binding.
Easy to manage. Few AE & extrapulmonary effects. Can cause hepatotoxicity but very rare. Hepaticall metabolized. ORAL |
|
|
Term
Anti-Inflammatory/Astma
Anti-IgE Antibody
Omalizumab |
|
Definition
Mouse to human monoclonal antibody binds to IgE. So decrease IgE. Prevents binding of IgE to mast cells. Down regulation of receptors.
Sub-Q every 2-4 weeks.
AE: Rare triggering of an immune response |
|
|
Term
|
Definition
- hyperuricemia >7 and Crystalizations in tisures and joints and inflammation.
- MOA: happens by decrease in urinary excretion or an increase in metabolic synthesis
- Types: Primary-defect in purine metabolism and or uric acid excretion. Secondary: Cancer, CRF, Drugs(salicylates, antineoplastic agents, diuretics, ethambutol, nicotinic acid, cyclosporin, ethanol.
- Goals of Gout Therapy: relief of pain anfd inflammation, termination of acute attacks, reduction in frequency and severity of attacks
|
|
|
Term
Gout Medications
Colchine (Acute Gout)
inhibits microtubule assembly. Indicated for Acute Attacks. |
|
Definition
Uses: treatment of acute attacks (rarly used now) and prophylaxis in patients with chronic gout.
MOA: Disruption of urate depostiton and subsequent inflammatory response. Specific treatment of gout. NO effects on uric acid levels.
AE: Abdominal pain, n/v/d
DI: Can be Severe need to watch will all drugs.
Results in high levels cyclosporine, tacrolimus, verapamil. because secreated in urine and bile.
|
|
|
Term
Gout Medications
Probenecid (Chronic)- increases secretion of uric acid. does not treat acute episode. |
|
Definition
Uses: prophylactic treatment. Prevention of disease progression, not useful in flair up (Acute attacks)
AE: Hypersensitivity, GI Distress
MOA: decrease urate reabsorption on the proximal tubules (so stays in kidney and gets eleminated)
Can lead to a variety of drug interactions (penicillin=increase levels of probenecid)
Precautions: DO NOT initiate during acute attack because of kidney stones. can increase attacks during 6-12 months of therapy. Need to drink lots of fluid (>2L/day) to minimize stones. Also can give bicarb |
|
|
Term
Gout Medications
Allopurinol (Chronic)-Inhibitor of xanthine oxidase |
|
Definition
MOA: inhibits uric acid production
prodrug converted bvy cxanthine oxidase
as plasma uric acid decreases, dissolution of deposits can occur leading to disruption in urate equilibrium and acute attacks. - CAN GIVE W/ Colchicine
DI: Allupurinol when giving with azathioprine cases high high levels of 6-meracaptoprine. So need way lower dose of azathioprine. |
|
|
Term
|
Definition
1st response
Bacterial (granulocytes)
Parastic (eusinophils)
Antigen Presenting Cells. |
|
|
Term
|
Definition
Specific
Generated
Native vs. Foreign cell recognition
Humoral immunity
Celular immunity
Cytotoxic and T-helper cells |
|
|
Term
|
Definition
involved in inflammation and cellular signaling (prostaglandins, prostacylins, thromboxanes, leukotrienes)
Common precursor to eicosanoids is arachidonic acid.
End Products of Arachidonic Acid:
1. The prostaglandins (from cyclooxygenase metabolism) (PG) esp PGE2, PGF2alpha and PGD2 2. The Prostacyclines PGI2
3.. Thromboxane Tx A2 4.. The leukotrienes ( from lipoxygenase metabolism)
Drugs affecting this pathway:
NSAIDS/ Non-selective COX 1 inhibitors:
ASA, IBU, Naproxen, Etodoiac, Indomethacin
COX 2 Inhibitors: Celecoxib
Leukotrience Inhibitors: Montelukast, zafirlukast
Corticosteroids: Prednisone, methylprednisolone, dexamethsone |
|
|
Term
|
Definition
H1=Smooth muscle, vascular endothelium, brain
H2=pepcid-gastric parietal cells, cardiac muscle, mast cells, brain
H3=CNS, some peripheral nerves
H4=Hemopoetic cells, gastric mucosa |
|
|
Term
|
Definition
Vascular Smooth Muscle: erthema, venule dilation
Endothelium:bronchoconstrction
Peripheral Nerves: sensation, itching, pain
Heart: increase contractility
Stomach: PUD
Not used for anaphylaxix
|
|
|